0001127602-21-003799.txt : 20210203 0001127602-21-003799.hdr.sgml : 20210203 20210203180544 ACCESSION NUMBER: 0001127602-21-003799 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210201 FILED AS OF DATE: 20210203 DATE AS OF CHANGE: 20210203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lucchino David L. CENTRAL INDEX KEY: 0001785288 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39062 FILM NUMBER: 21587717 MAIL ADDRESS: STREET 1: C/O FREQUENCY THERAPEUTICS, INC. STREET 2: 19 PRESIDENTIAL WAY, 2ND FLOOR CITY: WOBURN STATE: MA ZIP: 01801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Frequency Therapeutics, Inc. CENTRAL INDEX KEY: 0001703647 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472324450 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 19 PRESIDENTIAL WAY, SUITE 203 CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: 781-315-4600 MAIL ADDRESS: STREET 1: 19 PRESIDENTIAL WAY, SUITE 203 CITY: WOBURN STATE: MA ZIP: 01801 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-02-01 0001703647 Frequency Therapeutics, Inc. FREQ 0001785288 Lucchino David L. C/O FREQUENCY THERAPEUTICS, INC. 19 PRESIDENTIAL WAY, 2ND FLOOR WOBURN MA 01801 1 1 President and CEO Common Stock 2021-02-01 4 M 0 33102 .61 A 341188 D Common Stock 2021-02-01 4 S 0 2900 41.2949 D 338288 D Common Stock 2021-02-01 4 S 0 18600 42.8548 D 319688 D Common Stock 2021-02-01 4 S 0 8900 43.7142 D 310788 D Common Stock 2021-02-01 4 S 0 2702 44.5815 D 308086 D Stock Option .61 2021-02-01 4 M 0 33102 0 D 2028-05-21 Common Stock 33102 204549 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2020. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $40.87 to $41.695. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $42.2950 to $43.2800. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $43.3100 to $44.2400. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $44.4400 to $44.7250. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2018, and will be fully vested and exercisable on January 1, 2022. /s/ Michael D. Bookman, Attorney-in-Fact for David L. Lucchino 2021-02-03